ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,367
Screening encounters
3,897
Diagnostic referrals
744
Outstanding pathways
280

Screening pathway

  1. Screening3,897Encounters
  2. Positive finding1,352Documented findings
  3. Referral744Diagnostic referrals
  4. Follow-up872Diagnostic visits
  5. Outcome464Resolved pathways

Stage totals use different units. Pending pathways: 280. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2125 · EXP-2125Synthetic · Site B

Full participant history through 2026-08-24, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2028-06-07

Referral-time risk

No matching referral was available at this observation date.

Screened participants

3367 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2077 · Expanded synthetic participant 2077Site C — Rural Outreach Programme
EXP-2078 · Expanded synthetic participant 2078Site B — Peri-Urban Access Programme
EXP-2079 · Expanded synthetic participant 2079Site A — Urban Referral Hub
EXP-2080 · Expanded synthetic participant 2080Site A — Urban Referral Hub
EXP-2081 · Expanded synthetic participant 2081Site D — Community Engagement Programme
EXP-2083 · Expanded synthetic participant 2083Site C — Rural Outreach Programme
EXP-2084 · Expanded synthetic participant 2084Site E — Resource-Constrained Navigation Programme
EXP-2087 · Expanded synthetic participant 2087Site C — Rural Outreach Programme
EXP-2090 · Expanded synthetic participant 2090Site D — Community Engagement Programme
EXP-2091 · Expanded synthetic participant 2091Site A — Urban Referral Hub
EXP-2092 · Expanded synthetic participant 2092Site D — Community Engagement Programme
EXP-2094 · Expanded synthetic participant 2094Site B — Peri-Urban Access Programme
EXP-2095 · Expanded synthetic participant 2095Site D — Community Engagement Programme
EXP-2096 · Expanded synthetic participant 2096Site D — Community Engagement Programme
EXP-2097 · Expanded synthetic participant 2097Site E — Resource-Constrained Navigation Programme
EXP-2098 · Expanded synthetic participant 2098Site D — Community Engagement Programme
EXP-2100 · Expanded synthetic participant 2100Site E — Resource-Constrained Navigation Programme
EXP-2102 · Expanded synthetic participant 2102Site D — Community Engagement Programme
EXP-2107 · Expanded synthetic participant 2107Site C — Rural Outreach Programme
EXP-2108 · Expanded synthetic participant 2108Site E — Resource-Constrained Navigation Programme
EXP-2110 · Expanded synthetic participant 2110Site D — Community Engagement Programme
EXP-2113 · Expanded synthetic participant 2113Site E — Resource-Constrained Navigation Programme
EXP-2115 · Expanded synthetic participant 2115Site A — Urban Referral Hub
EXP-2116 · Expanded synthetic participant 2116Site D — Community Engagement Programme
EXP-2119 · Expanded synthetic participant 2119Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1540
HPV DNA
1801
Cytology
556

Navigation activity

Barrier documented
641
Contact attempt
1089
Navigation intervention
274
Diagnostic booking
916
Diagnostic visit
872

Documented barriers

Contact difficulty
213
Transport difficulty
201
Appointment coordination
227

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.